Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Driving local excellence, delivering European results

5 November 2018

Medicines for Europe is glad to announce the occasion of […]

Read more

US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver

22 October 2018

The US patent and trademark office (USPTO), together with the […]

Read more

Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers

11 October 2018

There is a concrete risk that disproportionate influence on the […]

Read more

CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court

20 September 2018

An English Court has determined that the contested supplementary protection […]

Read more

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Read more

SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform

17 September 2018

Medicines for Europe welcomes the European Parliament’s Committee on Environment, […]

Read more

Multi-stakeholder workshop on biosimilar medicines a crucial milestone in achieving increased patient access to biological therapies

14 September 2018

Open

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Open

European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines – a guide for nurses

26 June 2018

Open

Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community

22 June 2018

Medicines for Europe is committed to bringing accessible, high quality […]

Read more

Subscribe to our newsletter